I resonate with what you wrote. Conferences are often tedious. Your analysis of JPM's unique impact is insightful. The magnitude of capital allocation discussed is significant. The Eli Lilly and Nvidia AI lab announcement truely highlights critical future direction. This was a valuable read.
I really hope something awesome comes from the AI colab. Turn peptide drugs into small molecules or find ways to build more efficient double, triple agonists.
I resonate with what you wrote. Conferences are often tedious. Your analysis of JPM's unique impact is insightful. The magnitude of capital allocation discussed is significant. The Eli Lilly and Nvidia AI lab announcement truely highlights critical future direction. This was a valuable read.
I really hope something awesome comes from the AI colab. Turn peptide drugs into small molecules or find ways to build more efficient double, triple agonists.
The Biotech Breakthroughs article seemed to be a foreshadow of the conference themes.
How do you feel about what GRAIL is doing in healthcare. Their Galleri test has been gaining a lot of traction recently.